Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2508
https://www.valueinhealthjournal.com/article/S1098-3015(14)04438-6/fulltext
Title :
Cost-Effectiveness and Long-Term Outcomes of Sovaldi (SOFOSBUVIR) for the Treatment of Chronic Hepatitis C Infected (HCV) Patients from a Swedish Societal Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04438-6&doi=10.1016/j.jval.2014.08.2508
First page :
A675
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1959